These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 7128542)

  • 1. Dose dependent modulation of receptor dynamics and uterine growth in immature rat by estradiol: importance of an additional nuclear binding at 24 hr for long-term (72 hr) uterine growth.
    Agarwal AK; Durani S; Setty BS
    Endokrinologie; 1982 Jun; 79(2):235-41. PubMed ID: 7128542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear bodies as structural indicators of estrogenic stimulation in uterine luminal epithelial cells.
    Padykula HA; Fitzgerald M; Clark JH; Hardin JW
    Anat Rec; 1981 Dec; 201(4):679-96. PubMed ID: 7340572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding characteristics of zearalenone analogs to estrogen receptors.
    Kiang DT; Kennedy BJ; Pathre SV; Mirocha CJ
    Cancer Res; 1978 Nov; 38(11 Pt 1):3611-5. PubMed ID: 698923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oestrogenic stimulation of uterine growth: relation to oestrogen receptor binding and the stimulation of nuclear type II oestradiol binding sites.
    Clark JH; Upchurch S; Markaverich BM
    J Endocrinol; 1981; 89 Suppl():47P-57P. PubMed ID: 7241020
    [No Abstract]   [Full Text] [Related]  

  • 5. An endogenous inhibitor of [3H]estradiol binding to nuclear type II estrogen binding sites in normal and malignant tissues.
    Markaverich BM; Roberts RR; Alejandro MA; Clark JH
    Cancer Res; 1984 Apr; 44(4):1515-9. PubMed ID: 6704964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study of antiestrogen action: temporal patterns of antagonism of estrogen stimulated uterine growth and effects on estrogen receptor levels.
    Ferguson ER; Katzenellenbogen BS
    Endocrinology; 1977 May; 100(5):1242-51. PubMed ID: 849721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of low dose continuous exposure to estradiol on the estrogen receptor (type I) and nuclear type II sites.
    Markaverich BM; Roberts RR; Alejandro M; Clark JH
    Endocrinology; 1984 Mar; 114(3):814-20. PubMed ID: 6697964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. beta-Diethylaminoethyl-2, 2-diphenylpentanoate (SKF 525-A)-mediated translocation of uterine estrogen receptor from the cytosolic to the nuclear compartment in isolated rat uteri.
    Bulger WH; Kupfer D
    Mol Pharmacol; 1982 May; 21(3):533-7. PubMed ID: 7110114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of estrogen and its receptor to rat liver growth and regeneration.
    Fisher B; Gunduz N; Saffer EA; Zheng S
    Cancer Res; 1984 Jun; 44(6):2410-5. PubMed ID: 6722782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Properties of alkylating derivatives of estrogens].
    Morozova TM; Merkulova TI; Martynov V; Iaguzhinskaia VP; Shkodinskaia EN
    Eksp Onkol; 1984; 6(2):50-4. PubMed ID: 6510335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of estrogen action during preimplantation period and in immature estradiol-primed rat uterus by anti-implantation agent, ormeloxifene.
    Dwivedi A; Basu R; Chowdhury SR; Goyal N
    Contraception; 2005 Jun; 71(6):458-64. PubMed ID: 15914137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear binding of the estrogen receptor: heterogeneity of sites and uterotropic response.
    Clark JH; Markaverich B; Upchurch S; Eriksson H; Hardin JW
    Adv Exp Med Biol; 1979; 117():17-46. PubMed ID: 474276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential response of individual uterine cell types from immature rats treated with estradiol.
    McCormack SA; Glasser SR
    Endocrinology; 1980 May; 106(5):1634-49. PubMed ID: 6153974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative analysis of the interaction of various estrogens with the estrogen-receptor system of the uterus].
    Fanchenko ND; Alekseeva ML; Minina LS; Novikov EA; Khel'mun DK
    Biokhimiia; 1985 Nov; 50(11):1853-8. PubMed ID: 4063405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear interaction of Fusarium mycotoxins with estradiol binding sites in the mouse uterus.
    Greenman DL; Mehta RG; Wittliff JL
    J Toxicol Environ Health; 1979 Jul; 5(4):593-8. PubMed ID: 490675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the pharmacologic profile of a standardized soy extract in the ovariectomized rat model of menopause: effects on bone, uterus, and lipid profile.
    Gallo D; Zannoni GF; Apollonio P; Martinelli E; Ferlini C; Passetti G; Riva A; Morazzoni P; Bombardelli E; Scambia G
    Menopause; 2005; 12(5):589-600. PubMed ID: 16145313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogenic activity of zearalenone and zearalanol in the neonatal rat uterus.
    Sheehan DM; Branham WS; Medlock KL; Shanmugasundaram ER
    Teratology; 1984 Jun; 29(3):383-92. PubMed ID: 6235618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen receptor binding and growth of the reproductive tract.
    Clark JH; Hardin JW; McCormack SA
    Pediatrics; 1978 Dec; 62(6 Pt 2):1121-7. PubMed ID: 724349
    [No Abstract]   [Full Text] [Related]  

  • 19. Enhancement of estradiol potency by the 17 beta-hydroxysteroid dehydrogenase inhibitor, 16-methylene E2 in vivo.
    McDonald ZA; Slikker W; Fu PP; Bailey JR; Lipe GW; Unruh LE
    J Pharmacol Exp Ther; 1988 Feb; 244(2):428-31. PubMed ID: 2831339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo estrogenic and antiestrogenic activity of phenolphthalein and derivative compounds.
    Nieto A; García C; López de Haro MS
    Biochem Int; 1990; 21(2):305-11. PubMed ID: 2403370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.